|
LGE positive (N = 10)
|
LGE negative (N = 34)
|
P
|
---|
Age, yrs
|
40.4 ± 16.1
|
31.6 ± 15.8
|
0.131
|
Male (n, %)
|
6 (60)
|
12 (35.3)
|
0.273
|
Heart rate, bpm
|
78.1 ± 7.8
|
84.7 ± 13.4
|
0.147
|
BMI, kg/m2
|
22.8 ± 4.8
|
21.4 ± 4.8
|
0.428
|
NYHA classification
|
2.3 ± 0.5
|
1.8 ± 0.5
|
0.011
|
SO2 at rest, %
|
95.1 ± 2.6
|
97.1 ± 2.5
|
0.042
|
Severe TR (n, %)
|
8 (80.0)
|
24 (70.6)
|
0.557
|
ASD/PFO (n, %)
|
7 (70.0)
|
22 (64.7)
|
1.000
|
W-P-W (n, %)
|
1 (10.0)
|
5 (14.7)
|
0.950
|
QRS width, ms
|
114.2 ± 19.0
|
113.5 ± 15.2
|
0.910
|
LV EDV index, ml/m2
|
62.5 [12.6]
|
71.1 [21.2]
|
0.233
|
LV ESV index, ml/m2
|
30.6 [5.6]
|
33.7 [15.3]
|
0.537
|
LV EF, %
|
49.2 ± 10.5
|
53.7 ± 6.7
|
0.106
|
fRV EDV index, ml/m2
|
194.5 [87.7]
|
127.4 [57.4]
|
0.007
|
fRV ESV index, ml/m2
|
123.6 [64.4]
|
67.4 [28.7]
|
< 0.001
|
fRV EF, %
|
40.1 ± 12.7
|
45.0 ± 11.1
|
0.251
|
aRV EDV index, ml/m2
|
107.6 ± 76.16
|
62.4 ± 35.9
|
0.011
|
Total R/L-Volume-Index
|
6.9 ± 3.4
|
3.5 ± 1.7
|
0.011
|
SI
|
1.1 ± 0.4
|
0.9 ± 0.4
|
0.195
|
- Abbreviations: LGE late gadolinium enhancement; BMI body mass index; NYHA New York Heart Association; TR tricuspid regurgitation; ASD atrial septal defect; PFO patent foramen ovale; W-P-W Wolff-Parkinson-White; LV left ventricle; EDV end diastolic volume; ESV end systolic volume; EF ejection fraction; fRV functional right ventricle; aRV atrialized right ventricle; Total R/L-Volume-Index, total right/left volume index; SI severity index